Replies to post #144220 on Anavex Life Sciences Corp (AVXL)

[whippinsaw]

Aricept, one of the few drugs approved for alzheimer's, uses a similar moa as anavex.


Made phizer and a lot of investers fortunes. There are competitors that target the Sigma 1.

[Steady_T]

No competitors with the same or similar MOA because nobody sees any value in AVXL's approach. Neither do serious investors.

That may be true, but it doesn't mean they are right.

Paradigm shifts are like that. Clearly there is a paradigm shift going on considering all of the BP that are bailing out on AD research.

It will be the dark horse that wins the race. Why, because all of the others have dropped out.

Don't know if it is 2-73 that will be the dark horse that wins, however all of the favorites have fallen by the way side.

[The Mongoose]

So the serious investor can keep chasing the tau and amyloid theories, that's fine, and realize this is a failed theory as the big companies who are pulling their money out of the space have already figured out...I'll stick to investing based on the credibility of the science, which only has two realistic horses in the race AVXL and Neurotrope...I will bet on AVXL because it is easier to give, far better safety margin and has aligned its stars with success (follow the scientist, follow the money, follow the government involvement = AVXL)...I also will chose to believe the earth is round while the serious investor can keep chasing the earth is flat approach...then we will see who is right...good luck, maybe the world really is flat...
Go AVXL

[Investor2014]

See that's thing, if only Anavex instead had come with a take on plaque attack we wouldn't have been in this mess now.